Document Detail


Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis.
MedLine Citation:
PMID:  22267329     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular disease. Lipid changes related to inflammation have been described in RA. Tumour necrosis factor α (TNFα) inhibitor (TNFi) treatment is effective in controlling inflammation and decreasing the number of cardiovascular events.OBJECTIVE: To assess the change in lipid levels with TNFi treatment in patients with RA by systematic review and meta-analysis.METHODS: A Medline search was performed for articles published up to March 2011. Reports describing values for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TGs), atherogenic index (AI) and apolipoprotein B/A (apoB/A) collected before and after TNFi initiation were included. Data were analysed according to short-, mid- and long-term treatment. Statistical analysis of pre-post data was performed by comprehensive meta-analysis. A random effects model was used when there was evidence of heterogeneity.RESULTS: The search retrieved 32 articles, of which 13 prospective before/after studies were analysed. Long-term TNFi treatment was associated with increased levels of HDL (+0.27 mmol/l, p<0.0001) and TC (+0.27 mmol/l, p=0.03), whereas LDL levels and AI remained unchanged. After long-term treatment, TG levels increased (+0.28 mmol/l, p<0.001) and apoB/A decreased (-0.3, p<0.0001).CONCLUSION: The presumed cardioprotective effects of TNFi in RA do not seem to be explained by quantitative lipid changes since long-term treatment has no effect on LDL levels or on AI. Increased HDL levels could have some beneficial effects, but this needs to be confirmed by prospective studies with long-term follow-up.
Authors:
Claire Immediato Daïen; Yohan Duny; Thomas Barnetche; Jean-Pierre Daurès; Bernard Combe; Jacques Morel
Related Documents :
79759 - Plasma-triglycerides in regulation of h.d.l.-cholesterol levels.
8993109 - Treatment of hypercholesterolemia in patients undergoing multiple coronary angioplasties.
11772869 - Increased plasma c-reactive protein in familial hypoalphalipoproteinemia: a proinflamma...
20224839 - Tracking of lipids in schoolchildren: a four-year followup, population-based study in s...
15066369 - Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials.
6838689 - Plasma lipoprotein cholesterol in india in healthy persons and those with coronary hear...
2928269 - Cigarette craving and subsequent coping responses among smoking cessation clinic partic...
3795859 - Diet and breeding performance in cats.
9644269 - Cholesteryl ester transfer protein reaction between plasma lipoproteins.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-20
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  -     ISSN:  1468-2060     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Département de Rhumatologie, Hôpital Lapeyronie, Université de Montpellier 1, Montpellier, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagno...
Next Document:  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthr...